Aluda was founded around the idea that we need new approaches to drug discovery to find fundamentally new categories and identify better, more powerful intervention points against disease. We bring a deep, networked view of existing drug MOAs and screening approaches for of the past 30 years, from pathways to genetics, as well as a knowledge of fundamental cell biology. Our focus is on novel targets that have been unseen and under-recognized versus their impact on the complex nature of disease.
Disease is always complex — it is never one cause, one event — and the relationship between its many features is not always linear or related. Existing precision and targeted strategies have not made enough progress against the toughest challenge — when and how it progresses to multi-factor, multi-feature forms that evade and escape existing treatments. We seek to find a new generation of targets with broader roles that block more of disease for a leap forward for patients.
Address
CaliforniaUnited States
